Yuan Lei, Qu Chen, Zhao Jinhang, Lu Lijun, Chen Jiaping, Xu Yan, Li Xiaoning, Mao Tao, Yang Guoping, Zhen Shiqi, Liu Sijun
Department of Social Medicine and Health Education, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu Province 211166, China.
Department of Health Education, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu Province 210009, China.
Prev Med Rep. 2024 Aug 6;46:102852. doi: 10.1016/j.pmedr.2024.102852. eCollection 2024 Oct.
A high body mass index (BMI) increases the risk of hypertension. However, little is known about the dose-dependent association between BMI and hypertension. Therefore, this study investigated the prevalence of hypertension in 7568 subjects from the Jiangsu Province, Eastern China, and analyzed the dose-response relationship between BMI and hypertension risk.
The eligible subjects completed a structured questionnaire and clinical biochemical indicators were measured according to standardized protocols. Multivariate logistic regression models were used to evaluate the association between BMI and hypertension. Restricted cubic spline (RCS) analysis was used to analyze the dose-response relationship between BMI and hypertension risk. Moreover, sensitivity analysis was performed to verify the robustness of our findings.
The prevalence of hypertension was 35.3 % in the total population. BMI was significantly associated with systolic and diastolic blood pressure. The fully-adjusted odds ratio (OR) with 95 % confidence interval (CI) for hypertension was 1.17 (1.15, 1.19) for every 1 kg/m increase in BMI. Furthermore, the OR (95 % CI) for hypertension in the highest BMI group (Obesity) was 4.14 (3.45, 4.96) after adjusting for covariates compared with the normal group. Multivariable adjusted RCS analysis showed a positive and linear dose-response relationship between BMI and hypertension risk both in male and female populations (all for non-linearity > 0.05).
Our study demonstrated a positive and linear dose-response relationship between BMI and the risk of hypertension. The results of this study provide evidence for BMI-related clinical interventions to reduce the risk of hypertension.
高体重指数(BMI)会增加患高血压的风险。然而,关于BMI与高血压之间的剂量依赖关系知之甚少。因此,本研究调查了中国东部江苏省7568名受试者的高血压患病率,并分析了BMI与高血压风险之间的剂量反应关系。
符合条件的受试者完成一份结构化问卷,并按照标准化方案测量临床生化指标。使用多变量逻辑回归模型评估BMI与高血压之间的关联。采用受限立方样条(RCS)分析来分析BMI与高血压风险之间的剂量反应关系。此外,进行了敏感性分析以验证我们研究结果的稳健性。
总人群中高血压患病率为35.3%。BMI与收缩压和舒张压显著相关。BMI每增加1kg/m²,高血压的完全调整优势比(OR)及其95%置信区间(CI)为1.17(1.15,1.19)。此外,与正常组相比,在调整协变量后,最高BMI组(肥胖)中高血压的OR(95%CI)为4.14(3.45,4.96)。多变量调整后的RCS分析显示,在男性和女性人群中,BMI与高血压风险之间均存在正线性剂量反应关系(所有P值均大于0.05,表示不存在非线性关系)。
我们的研究表明BMI与高血压风险之间存在正线性剂量反应关系。本研究结果为与BMI相关的临床干预措施降低高血压风险提供了证据。